Freedom of Information

1. How many patients has your trust/health board treated in the past 6 months (for any disease) with the following drugs:

• Aubagio (teriflunomide)
• Avonex (interferon beta-1a)
• Betaferon (interferon beta-1b)
• Brabio (glatiramer acetate)
• Copaxone (glatiramer acetate)
• Extavia (beta interferon-1b)
• Gilenya (fingolimod)
• Lemtrada (alemtuzumab)
• Kesimpta (ofatumumab)
• Mavenclad (cladribine)
• Mayzent (siponimod)
• Ocrevus (ocrelizumab)
• Plegridy (peginterferon beta-1a)
• Ponvory (ponesimod)
• Rebif (beta interferon-1a)
• Tecfidera (dimethyl fumarate)
• Tysabri (natalizumab)
• Tysabri (natalizumab) pre-filled syringes ONLY
• Vumerity (diroximel fumarate)
• Zeposia (ozanimod)

2. How many patients are registered with your trust/health board for the following conditions:

• Multiple sclerosis (any type)
• Relapsing remitting multiple sclerosis (RRMS)
• Primary progressive multiple sclerosis (PPMS)
• Secondary progressive multiple sclerosis (SPMS)